The Global Therapeutic Nuclear Medicine Market is emerging as a critical segment within advanced healthcare, driven by the growing demand for targeted cancer therapies and precision medicine. Therapeutic nuclear medicine uses radioactive substances to treat diseases at the cellular level, enabling clinicians to destroy diseased tissues while minimizing damage to surrounding healthy cells. This approach is gaining strong acceptance across oncology and other therapeutic areas due to its effectiveness, safety profile, and ability to address complex conditions that are difficult to treat using conventional therapies.
